(Q42262216)

19 October 2017

title

Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine in spontaneously hypertensive rats (English)

1 reference

19 October 2017

1 reference

Ferrone RA

1

1 reference

19 October 2017

Heran CL

series ordinal

2

1 reference

19 October 2017

Antonaccio MJ

series ordinal

3

1 reference

19 October 2017

publication date

1 February 1980

1 reference

Clinical and Experimental Hypertension

19 October 2017

published in

1 reference

19 October 2017

volume

2

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

247-272

1 reference

The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

Mechanisms of Antihypertensive Drug Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

GUANETHIDINE AND METHYLDOPA: A HAeMODYNAMIC STUDY

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009046423

10.3109/10641968009046423

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference